A MURINE MONOCLONAL-ANTIBODY DETECTING N-ACETYL-GM2 AND N-GLYCOLYL-GM2 - CHARACTERIZATION OF CELL-SURFACE REACTIVITY

Authors:
  • ENEJ NATOLI
    EJ NATOLI
  • PLPO LIVINGSTON
    PO LIVINGSTON
  • CPCS PUKEL
    CS PUKEL
  • KLKO LLOYD
    KO LLOYD
  • HWH WIEGANDT
    H WIEGANDT
  • JSJ SZALAY
    J SZALAY
  • HOHF OETTGEN
    HF OETTGEN
  • LOLJ OLD
    LJ OLD

  • 1 August 1986
    • journal article
    • research article
    • Vol. 46  (8) , 4116-4120
    • PMID:3731079
Abstract
Antisera reactive with the ganglioside GM2 were raised by immunizing C57BL/6 mice with the C57BL/6 melanoma JB-RH. Fusion with NS-1 was performed using splenic mononuclear cells from a mouse with high antibody titer. An immunoglobulin M monoclonal antibody (monoclonal antibody 5-3) was identified which was reactive with an antigen that was resistant to heat, trypsin, and Pronase. A panel of purified glycolipids was used to determine the specificity of monoclonal antibody 5-3. Reactivity was restricted to N-acetyl- and N-glycolyl-GM2. No reactivity was detected with asialo-GM2 or other gangliosides. Monoclonal antibody 5-3 was used to define the expression of GM2 on the cell surface of cultured human normal and malignant cells. Reactivity was seen with cell lines derived from 8 of 8 astrocytomas, 5 of 5 neuroblastomas, 7 of 9 sarcomas, 4 of 18 human melanomas, 2 of 4 murine melanomas, 4 of 37 epithelial cancers and with 0 of 6 skin fibroblast and 0 of 2 brain fibroblast lines. GM2, like GD2 and GD3, appears to be a differentiation antigen largely restricted to cells of neuroectodermal origin.

This publication has 19 references indexed in Scilit: